Voloridge Investment Management, LLC Gossamer Bio, Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $2.45 Million - $5.05 Million
339,206 New
339,206 $4.06 Million
Q4 2020

Feb 16, 2021
SELL
$8.3 - $13.59 $99,301 - $162,590
-11,964 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $135,193 - $176,469
11,964 New
11,964 $148,000
Q2 2020

Aug 14, 2020
SELL
$9.52 - $15.98 $194,769 - $326,934
-20,459 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$8.0 - $15.48 $163,672 - $316,705
20,459 New
20,459 $208,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email